ClinicalTrials.govpublic full text
The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
psoriasis, cardiovascular diseases, diabetes mellitus, type 2, adalimumab, fumaric acid esters, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 916751
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.